Explained herein are pharmaceutical packaging programs which avert oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive drugs, such methods such as a syringe having an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to oxygen and compris